Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,012,347
+$140,865 QoQ
Shares Held
4,023
+0.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#2,526
of 4,153 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KNIGHTSBRIDGE ASSET MANAGEMENT, LLC holds $7,232,871 across 7 Drug Manufacturers - General names. ABBV ranks #3 (14.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,809 | $2,169,769 | |
| 2 | JNJ |
Johnson & Johnson
|
4,111 | $1,044,070 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
4,023 | $1,012,347 | |
| 4 | MRK |
Merck & Co., Inc.
|
7,055 | $906,567 | |
| 5 | NVS |
Novartis AG
|
5,345 | $837,668 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
11,934 | $687,637 | |
| 7 | PFE |
Pfizer Inc
|
23,871 | $574,813 |
All Filings in ABBV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,012,347 | 4,023 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $871,482 | 4,007 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $892,938 | 3,908 | Shares | Sole | 2026-05-15 | |
| 2025-09-30 | $850,677 | 3,674 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $521,035 | 2,807 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $379,231 | 1,810 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $205,065 | 1,154 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||